메뉴 건너뛰기




Volumn 21, Issue 4, 2013, Pages 371-374

Impact of clinical pharmacist on cost of drug therapy in the ICU

Author keywords

Clinical pharmacist; Cost saving; Drugs consumption; Intensive care unit

Indexed keywords

ACICLOVIR; ADRENALIN; AMIKACIN; ANTIINFECTIVE AGENT; AZITHROMYCIN; CARDIOVASCULAR AGENT; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CILASTATIN; DOBUTAMINE; DOPAMINE; FLUCLOXACILLIN; FLUCONAZOLE; FUROSEMIDE; GENTAMICIN; GLYCERYL TRINITRATE; HEPARIN; HYDRALAZINE; IMIPENEM; LABETALOL; METRONIDAZOLE; NIMODIPINE; PENICILLIN G; PROSTAGLANDIN E1; TAZOBACTAM; TINZAPARIN; UNINDEXED DRUG; VANCOMYCIN;

EID: 84884593953     PISSN: 13190164     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsps.2012.12.004     Document Type: Article
Times cited : (22)

References (6)
  • 1
    • 84884597459 scopus 로고    scopus 로고
    • American College of Clinical Pharmacy ACCP, [online]. Clinical Pharmacy Defined, (Accessed 03.09.12)
    • American College of Clinical Pharmacy ACCP, 2012. [online]. Clinical Pharmacy Defined. <> (Accessed 03.09.12). http://www.accp.com/about/clinicalPharmacyDefined.aspx.
    • (2012)
  • 6
    • 70349207741 scopus 로고    scopus 로고
    • Impact of pharmacist's interventions on cost of drugs therapy in intensive care unit
    • Saokaew S., Maphanta S., Thangsomboon P. Impact of pharmacist's interventions on cost of drugs therapy in intensive care unit. Pharmacy Practices 2009, 7(2):81-87.
    • (2009) Pharmacy Practices , vol.7 , Issue.2 , pp. 81-87
    • Saokaew, S.1    Maphanta, S.2    Thangsomboon, P.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.